EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots

Content Curator
Boxes containing the Johnson & Johnson COVID-19 vaccine, developed by the company

While emphasizing that the risk is low, the health agency said there should be a warning about the rare condition included in the product information for the vaccine.

(Image credit: Allen J. Schaben/Los Angeles Times via Getty Images)